The CEOs of seven multinational pharmaceutical companies have announced that they are taking joint action to achieve near-term emissions reduction targets and accelerate the delivery of net zero health systems.
Both houses of the US Congress have passed the White House’s $430 billion bill, which could decisively shape issues as diverse as pharmaceutical pricing and greenhouse gas emissions.
The mission of the US Environmental Protection Agency (EPA) under US president Joe Biden for the past 18 months has been to restore some of the Obama era anti-pollution regulations overturned by the former president Donald Trump.
